Open to PhD applications in the field of
- Pharmaceutical Materials Science and Formulation
- Drug Delivery and Biomaterials
Public outreach & key achievements
- Karl's research group has worked closely with The International Partnership for Microbicides to help develop the first vaginal ring offering sustained release of the antiretroviral microbicide dapivirine for prevention of sexual transmission of HIV. The dapivirine ring has recently completed Phase III clinical testing, and subject to review by regulatory bodies, will likely be available to users in 2018. Second generation ring devices for HIV prevention and contraception are currently in early state clinical testing.
|PhD Title||Development of 3D Printed Drug Delivery Devices|
|Year of Study||2015 - 2018|